Navigation Links
Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
Date:7/3/2012

HOFFMAN ESTATES, Ill., July 3, 2012 /PRNewswire/ -- "We believe that an individual's access to HIV testing in the privacy of their own home is critical to knowing their HIV status.  It's our hope that FDA's approval of another at-home testing option will add to the body of knowledge surrounding risk factors for HIV, increase overall testing, and reduce the rates of transmission of this dangerous virus.  It's important for those who choose to test at home to understand the options available in the marketplace and the significant differences between the accuracy of the Home Access test service that both screens and confirms preliminary positive results, and products that only screen for results and do not include confirmation testing.  We believe that it's important for consumers to have the best opportunity for accurate, complete HIV testing from home, with ready access to counseling by trained HIV professionals."

About Home Access Health Corporation

Home Access Health Corporation (HAHC) was founded in 1993 to provide anonymous, direct-to-consumer laboratory test services using self-collected fingerstick blood.  Individuals collect, package and send a small fingerstick blood specimen to the Company's CAP-accredited laboratory, using components provided in the Home Access test kits.  HAHC received FDA approval for its HIV-1 Test System in 1996 and immediately launched a national consumer awareness campaign.

In 1998, responding to the U.S. Surgeon General's order for public health departments (and other healthcare entities) to combat Hepatitis C (HCV), the company adapted its HIV platform and fast-tracked clinical trials and regulatory filings, resulting in an FDA approval for Home Access® Hepatitis C Check test service in 1999.  HAHC markets its HCV test primarily through public health departments.

In 2007, the Company received FDA clearance for its complete Cholesterol Panel, a comprehensive laboratory test system that uses self-collected fingerstick blood to measure total cholesterol, HDL-cholesterol, Triglycerides and LDL-cholesterol.  The accuracy levels of the Cholesterol Panel achieve the standards established by the National Cholesterol Education Program and the test method has been certified by the CDC-sponsored National Cholesterol Reference Method Laboratory Network.

The Home Access FDA-approved test system for HIV-1 and Hepatitis C are sold directly to consumers without the need for physician intervention. (http://www.fda.gov/consumer/updates/hivtestkit012908.html).  These tests are anonymous, include confirmatory testing, and access to the HAHC counseling center for results delivery, counseling, and referrals.


'/>"/>
SOURCE Home Access Health Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Statement on Affordable Care Act Ruling by Supreme Court
2. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in the U.S. Senate
3. Lilly Statement on PDUFA Vote by Senate
4. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in House of Representatives
5. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
6. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
7. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
8. Icahn Issues Statement Regarding Amylin Pharmaceuticals
9. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
10. Wake Forest Baptist Names President of Piedmont Triad Research Park and Chief Innovation Officer
11. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Dec 9, 2016 Research and Markets ... 2016-2020" report to their offering. ... The report forecasts the global optical transceiver ... 2016-2020. The report covers the present scenario and ... To calculate the market size, the report considers the revenue generated ...
(Date:12/9/2016)... Dec. 9, 2016  Harmar Mobility, LLC announced today that Steven ... of the Board of Directors. Photo - http://photos.prnewswire.com/prnh/20161209/447552 ... ... Mr. Dawson,s executive career includes ... across a variety of industries. He brings to the company deep ...
(Date:12/9/2016)... Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... of Physiocrine-based therapeutics to address severe, rare diseases, today announced that ... BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel ... 14, 2016, at 4:20 p.m. ET. About aTyr ... aTyr ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, ... announced today that a new solution for Emergency Departments (ED) has been added ... space in Emergency Department examination rooms, and with a simplified pallet of information ...
(Date:12/8/2016)... ... 08, 2016 , ... After enjoying record-breaking attendance at its ... its 33rd Annual Issues & Research Conference, March 2-3, 2017, at the ... conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." ...
(Date:12/8/2016)... Plainsboro, NJ (PRWEB) , ... December 08, 2016 , ... ... patients, cancer centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts ... In making the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching of ... Unified Instance Manager architecture, meeting the needs of multichannel growth and doubling ... unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):